Raul Collazo
Technik-/Wissenschafts-/F&E-Leiter bei CONNECT BIOPHARMA HOLDINGS LIMITED
Aktive Positionen von Raul Collazo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 | - |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Raul Collazo
Ausbildung von Raul Collazo
| University of Oregon | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| China | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Health Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
- Börse
- Insiders
- Raul Collazo
- Erfahrung
